Reparixin, a CXCR1/2 inhibitor in islet allotransplantation

Quality of life in Type 1 diabetic patients may be improved with islet transplantation, but lifelong immunosuppression is required to prevent rejection. Allo-immune response is a key player in graft dysfunction and although the adaptive immune response is well characterized, the effect of the innate...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Islets
Auteurs principaux: Pawlick, Rena L., Wink, John, Pepper, Andrew R., Bruni, Antonio, Abualhassen, Nasser, Rafiei, Yasmin, Gala-Lopez, Boris, Bral, Mariusz, Shapiro, A.M. James
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029202/
https://ncbi.nlm.nih.gov/pubmed/27328412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19382014.2016.1199303
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires